First pharmaceutical drug to improve survival amongst patients w...

(Elhuyar Fundazioa) International research involving the University Hospital of the University of Navarra, together with other hospitals in Spain, has shown that Sorafenib, an orally administered pharmaceutical medicine, results in patients with primary hepatocarcinomas to live 40 percent more on average compared to those not taking the drug.


 

More related items

TECNALIA leads a composite materials project to...
(Elhuyar Fundazioa) The TECNALIA Technological Corporation is leading the Laysa European research project, focused on multifunctional layers in composite materials with the aim of attaining...

TECNALIA leads five projects within the VII Framework...
(Elhuyar Fundazioa) The TECNALIA Technological Corporation is leading five projects within the VII Framework Program with regard to the simulation of cement materials, nanomaterials for...

An Ikerbasque researcher disentangles the strange...
(Elhuyar Fundazioa) The study shows that certain quantum jumps are prohibited between the two levels of a qubit superconductor. The research, led by Enrique Solano, is published in Nature...

The Perfect Machine: Building the Palomar Telescope
Almost a half-century after is completion, the 200-inch Palomar telescope remains an unparalleled combination of vast scale and microscope detail. As huge as the Pantheon of Rome and as heavy...

Bushnell 20-60x60 Multi Position Spacemaster Spotting...
Spacemasters have set the standards by which all other spotting scopes have been judged for nearly two decades. And for good reason. Premium engineering and fully coated optics promise...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
Popular by tags

Week

  • -- no stats yet --


science-nature.marc8.com